Insider buying: Tenet director purchases 5k shares

Peter M. Wilver, independent director of Tenet Healthcare, recently bought 5,000 shares of the Dallas-based company, according to a Securities and Exchange Commission filing.

Based on an average market stock price of $15.19 per share, the total value of the transaction is approximately $75,950.

Mr. Wilver, who serves as executive vice president and chief administrative officer of Waltham, Mass.-based Thermo Fisher Scientific, was recently appointed to Tenet's board of independent directors along with John P. Byrnes. Tenet's board now consists of 14 directors, 13 of whom are independent.

More articles on healthcare finance:

6 strategies for hospital financial planning in an era of value, consumerism and growing drug costs
The most pressing issues for CFOs in 2017
Fair market value considerations for 6 steps of bundled payment program development

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Webinars

Featured Whitepapers